This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Exosomes Europe
3-5 November 2025
Amsterdam Marriott HotelAmsterdam, Netherlands

Spencer Marsh
Chief Scientific Officer at Tiny Cargo Company
Speaker

Profile

Dr. Spencer Marsh is the Chief Scientific Officer at The Tiny Cargo Company, who is commercializing the use of milk exosomes in the pharmaceutical and cosmeceutical industries. Tiny Cargo recently unveiled their industrial cGMP manufacturing facility, which produces multiple kilograms of highly purified milk exosomes weekly, representing a million-fold increase in manufacturing capabilities for milk exosomes. Tiny Cargo aims to implement milk exosomes as a flexible, orally administered and shelf-stable drug delivery platform for peptides, small molecules, monoclonal antibodies and more.

Agenda Sessions

  • The Unusual Suspects: Exploring Diverse Exosome Sources

    12:20
  • PANEL DISCUSSION: Stronger Together: Maximizing Impact Through Strategic Academic, Industry & Vendor Partnerships

    11:40